Phase 1 clinical trial of STK-01 in bladder cancer patients.
Phase of Trial: Phase I
Latest Information Update: 07 Jul 2017
At a glance
- Drugs Docetaxel (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 07 Jul 2017 New trial record
- 26 Jun 2017 According to a Sitka Biopharma media release, Cancer Research UKs Centre for Drug Development (CDD) will then fund and manage this trial.